The first joint Europe-wide assessment of the drivers and impact of chemical pollution by the European Environment Agency (EEA) and the European Chemicals Agency (ECHA) has concluded that, despite progress in some areas, “more work is still needed to reduce the impact of harmful substances on human health and the environment”. Key findings include:
* The transition towards safer and more sustainable chemicals is progressing in some areas but just getting started in others
* Action by authorities and industry has supported minimising and controlling the risks from several groups of hazardous chemicals. Efforts are ongoing to increase knowledge on chemical hazards and support risk management action where needed
* There has been little evidence of progress towards eliminating substances of concern from waste and secondary materials. This is a barrier to the transition towards a more circular economy
* Emissions of certain chemicals to water and air have fallen following specific EU regulations and international actions, but further measures are needed to reach concentration levels that are not harmful for human health and the environment. Emissions from industry still lead to major damage to both
* Human biomonitoring offers the opportunity to understand exposure to chemicals from multiple sources and thus health risks associated with chemical pollution. As such, it forms a key tool to measure the effectiveness of chemicals legislation
The report established that the use of the most harmful chemicals (in carcinogenic, mutagenic and reprotoxic (CMR) chemicals) is still growing albeit slower than the overall market. More needs to be done to avoid the use of substances of concern and to implement the principles of the safe and sustainable by design (SSbD) framework. The shift in that direction must be accelerated.
Reference:
https://www.specchemonline.com/more-work-needed-safety-sustainability
Today we announce that Exim is rebranding as ExSyn. We are presenting a new brand identity and website as a reflection of our relentless transformation over the course of 30 years serving the pharma and chemical industries. The new brand builds upon our core strengths as a sourcing company and captures our most essential duty: helping improve people’s health and lives.
Teprenone (Geranylgeranylacetone, GGA) is a mixture of the all-trans and mono-cis isomers of 6,10,14,18-tetramethyl-5,9,13,17-nonadecatetraen-2-one (in a weight ratio of 3:2). It is an acyclic isoprenoid compound with a structure like retinoids and is widely used for the treatment of gastrointestinal ulcers.
Ciclopirox Olamine (CPO) is the N-oxide of a 2 -hydroxy pyridine derivative that carries antifungal, antibacterial, and anti-inflammatory properties. It is composed of 6-cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone combined with 2 aminoethanol (olamine) in a 1:1 ratio.
N,N-Dimethylglycine sodium salt (DMG Na) is the sodium salt form of N,N-dimethylglycine, a tertiary amino acid derivative is white to off white crystalline solid, freely soluble in water.